Post-CPB Drug: Dobutamine Hydrochloride

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
58	肥大型心筋症	1

58. 肥大型心筋症

臨床試験数 : 126 / 薬物数 : 135 - (DrugBank : 42) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 162

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05025644 (ClinicalTrials.gov)	March 2023	11/8/2021	Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensi ...	Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensi ...	Hypertrophic Obstructive Cardiomyopathy	Drug: Pre and post-CPB Drug: Dobutamine Hydrochloride;Drug: Post-CPB Drug: Dobutamine Hydrochloride	University Health Network, Toronto	NULL	Not yet recruiting	18 Years	N/A	All	60	Phase 4	NULL

First Previous1Next Last